Findings from the first population study assessing the risk of breast cancer specific mortality among male breast cancer patients, was recently published in JAMA Oncology. As a diagnosis of breast cancer in males is rare, the disease trajectory, particularly with regards to inclusion of male breast cancer patients in clinical trials, has not been well studied. However, "the median age at diagnosis is substantially higher in men than in women, and patients with male breast cancer are more likely to have regional nodal involvement."
To learn more about this study, click here.
Source mentioned: Leone J, Hassett MJ, Freedman RA, et al. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. JAMA Oncology; Published online 29 February 2024. doi:10.1001/jamaoncol.2023.7194
No comments:
Post a Comment